205 related articles for article (PubMed ID: 37633889)
1. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals.
Wu R; Li X; Chen Z; Shao Q; Zhang X; Tang W; Hu B
BMC Pediatr; 2023 Aug; 23(1):426. PubMed ID: 37633889
[TBL] [Abstract][Full Text] [Related]
2. A novel clinical tool and risk stratification system for predicting the event-free survival of neuroblastoma patients: A TARGET-based study.
Li M; Duan X; Li C; You D; Liu L
Medicine (Baltimore); 2023 Sep; 102(38):e34925. PubMed ID: 37746942
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
4. A Novel Online Nomogram Established with Five Features before Surgical Resection for Predicating Prognosis of Neuroblastoma Children: A Population-Based Study.
Zhou Y; Gao J
Technol Cancer Res Treat; 2023; 22():15330338221145141. PubMed ID: 36604997
[No Abstract] [Full Text] [Related]
5. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma.
Sun Q; Chen Y; Jin Q; Yuan X
Eur J Pediatr; 2022 Dec; 181(12):4135-4147. PubMed ID: 36149505
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification.
Feng L; Kan Y; Wang W; Wang C; Zhang H; Xie P; Yang J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16377-16390. PubMed ID: 37702807
[TBL] [Abstract][Full Text] [Related]
7. A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
Moreno L; Guo D; Irwin MS; Berthold F; Hogarty M; Kamijo T; Morgenstern D; Pasqualini C; Ash S; Potschger U; Ladenstein R; Valteau-Couanet D; Cohn SL; Pearson ADJ; London WB
Pediatr Blood Cancer; 2021 Mar; 68(3):e28794. PubMed ID: 33205902
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.
Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W
Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361
[TBL] [Abstract][Full Text] [Related]
9. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
10. A practical nomogram and risk stratification system for predicting survival outcomes in neuroblastoma patients: a SEER population-based study.
Zhuo X; Xia L; Tang W; He W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12285-12296. PubMed ID: 37430162
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
[TBL] [Abstract][Full Text] [Related]
12. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
Front Public Health; 2022; 10():946299. PubMed ID: 36159305
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel nomogram for predicting overall survival patients with neuroblastoma.
Zhao JD; Lu XY; Chen TP; Duan XL; Zuo W; Sai K; Zhu LR; Gao Q
Eur J Surg Oncol; 2024 Apr; 50(6):108321. PubMed ID: 38598875
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a prognostic nomogram model incorporating routine laboratory biomarkers for preoperative patients with endometrial cancer.
Cong R; Li M; Xu W; Ma X; Wang S
BMC Cancer; 2023 Nov; 23(1):1167. PubMed ID: 38031022
[TBL] [Abstract][Full Text] [Related]
15. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
[TBL] [Abstract][Full Text] [Related]
16. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
[TBL] [Abstract][Full Text] [Related]
17. Nomogram based on nutritional and inflammatory indicators for survival prediction of small cell carcinoma of the esophagus.
Chen H; Liu CT; Hong CQ; Chu LY; Huang XY; Wei LF; Lin YW; Tian LR; Peng YH; Xu YW
Nutrition; 2021 Apr; 84():111086. PubMed ID: 33418231
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population-based analysis.
Zhao J; Li D; Xie S; Deng X; Wen X; Li J; Wu Z; Yang X; Li M; Tang Y; Zhang X; Ding Y
Front Immunol; 2022; 13():1083840. PubMed ID: 36618343
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
20. Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors.
Lu G; Li J; Wu L; Shi Y; Zhang X; Xia Y; Li L
Dig Dis; 2022; 40(1):50-61. PubMed ID: 33752202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]